Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Pharma industry seeks R&D sops, simplification of regulatory framework in Budget
Pharma industry seeks R&D sops, simplification of regulatory framework in Budget
BusinessLine

The government should look at offering globally competitive R&D incentives and fiscal support for clinical research to the domestic pharma industry in the upcoming Budget in order to help it transform into an innovation-led $130-billion sector by…

wsj.com - Markets Last Week: Defense Stocks Rose, Beer Beat, Pharma Deal
Markets Last Week: Defense Stocks Rose, Beer Beat, Pharma Deal
Wall Street Journal

How did American oil companies respond to the U.S. action in Venezuela? Why were Constellation investors happy with lower beer sales? Plus, can a big pharmaceutical deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana…

pitcher.com - Dorota - Smarter Compliance Support for Pharma Revenue Teams
Smarter Compliance Support for Pharma Revenue Teams
Pitcher

Pharma field teams walk a tightrope every day. There is patient safety, regulatory accuracy, and brand compliance on one side. On the other, the day-to-day urgency of engaging healthcare professionals and moving conversations forward. The problem…

zerohedge.com - Tyler Durden - Cancer Drugs Drive Nearly One-Fifth Of Pharma Sales
Cancer Drugs Drive Nearly One-Fifth Of Pharma Sales
Zero Hedge

The global pharmaceutical industry's revenue is increasingly concentrated in a handful of high-value drug classes, with oncology, diabetes/obesity treatments and immunology leading the charge. As Statista's Tristan Gaudiat details below, according…

bloomberg.com - Naomi Kresge - Abivax CEO Says Big Pharma Can't Ignore Its Experimental Drug
Abivax CEO Says Big Pharma Can't Ignore Its Experimental Drug
Bloomberg

Abivax SA's chief executive said major pharmaceutical companies can't ignore the potential of his firm's experimental inflammatory bowel disease drug, as the industry looks to replace hundreds of billions of dollars in sales set to evaporate due to…

thehindubusinessline.com - Young brigade rises in India's pharma sector
Young brigade rises in India's pharma sector
BusinessLine

At a recent informal gathering, Sun Pharmaceuticals Founder Dilip Shanghvi was asked about the younger brigade rising to become part of top management in domestic drug companies, as challenges loom at home and abroad. “They also have more…

247wallst.com - Rich Duprey - Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma's Future
Eli Lilly and Nvidia Make $1 Billion AI Bet to Revolutionize Pharma's Future
24/7 Wall St

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive amounts of data far faster than humans, identifying potential drug candidates and predicting their effects. This could cut…

thehindu.com - The Hindu Bureau - Alembic Pharma's generic cancer drug Bosutinib Tablets 400 mg gets U.S. FDA nod
Alembic Pharma's generic cancer drug Bosutinib Tablets 400 mg gets U.S. FDA nod
The Hindu

Alembic Pharmaceuticals has received tentative approval from the U.S. Food and Drug Administration (U.S. FDA) for its generic of cancer drug Bosutinib Tablets, 400 mg. Bosutinib Tablets, 400 mg, had an estimated market size of $251 million for the…

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Unusually-High Trading Volume - Still a Buy?
Zealand Pharma A/S (OTCMKTS:ZLDPF) Sees Unusually-High Trading Volume - Still a Buy?
MarketBeat

Shares of Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) saw unusually-strong trading volume on Monday. Approximately 1,480 shares changed hands during mid-day trading, an increase of 9% from the previous session's volume of 1,360 shares.The…

marketbeat.com - Tema Etfs LLC Sells 27,026 Shares of BridgeBio Pharma, Inc. $BBIO
Tema Etfs LLC Sells 27,026 Shares of BridgeBio Pharma, Inc. $BBIO
MarketBeat

Tema Etfs LLC reduced its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 21.9% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 96,561 shares of the…

marketbeat.com - Park Avenue Securities LLC Makes New Investment in Royalty Pharma PLC $RPRX
Park Avenue Securities LLC Makes New Investment in Royalty Pharma PLC $RPRX
MarketBeat

Park Avenue Securities LLC purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased…

dailymail.co.uk - Lauren Acton-taylor - Tucker Carlson's hollowed-out appearance sparks Ozempic rumors
Tucker Carlson's hollowed-out appearance sparks Ozempic rumors
Mail Online

Tucker Carlson 's dramatic change in appearance has sparked rumors that the hollowed-out political commentator is on a weight loss drug. Carlson, 56, was seen snapped with Florida Republican gubernatorial candidate James Fishback in a photo that…

cnbc.com - Jim Cramer - Jim Cramer's top 10 things to watch in the stock market Monday
Jim Cramer's top 10 things to watch in the stock market Monday
CNBC

My top 10 things to watch Monday, Jan. 12 1. The Justice Department has opened a criminal investigation into Federal Reserve Chairman Jerome Powell. It's another apparent attempt by President Donald Trump to influence the central bank's monetary…

globenewswire.com - ONCOVITA - Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir platform.
Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir platform.
GlobeNewswire

Oncovita announces a strategic partnership with Infinitusbio.AI to explore the design and optimize the development of new therapeutic candidates from its Measovir platform. San Diego, United-States and Paris, France – January 12, 2026.

qz.com - Shannon Carroll - Eli Lilly and Nvidia plan new AI lab to speed drug discovery
Eli Lilly and Nvidia plan new AI lab to speed drug discovery
Quartz

The doctor will see you now. It's an AI agent with a visitor badge — and an eight-figure monthly burn. Nvidia and Eli Lilly announced Monday that they're launching a co-innovation AI lab aimed at speeding up drug discovery — a…

Receive a Daily briefing on Pharma Industry News

Get Started